XML 15 R2.htm IDEA: XBRL DOCUMENT v3.5.0.1
Condensed Consolidated Balance Sheets (Unaudited) - USD ($)
$ in Thousands
Jun. 03, 2016
Nov. 27, 2015
[1]
Current assets:    
Cash and cash equivalents $ 886,379 $ 876,560
Short-term investments 3,432,029 3,111,524
Trade receivables, net of allowances for doubtful accounts of $5,723 and $7,293, respectively 666,736 672,006
Prepaid expenses and other current assets 253,420 161,802
Total current assets 5,238,564 4,821,892
Property and equipment, net 796,077 787,421
Goodwill 5,444,556 5,366,881
Purchased and other intangibles, net 494,193 510,007
Investment in lease receivable 80,439 80,439
Other assets 162,954 159,832
Total assets 12,216,783 11,726,472
Current liabilities:    
Trade payables 75,582 93,307
Accrued expenses 661,013 679,884
Income taxes payable 15,774 6,165
Deferred revenue 1,633,221 1,434,200
Total current liabilities 2,385,590 2,213,556
Long-term liabilities:    
Debt 1,918,389 1,907,231
Deferred revenue 48,411 51,094
Income taxes payable 273,221 256,129
Deferred income taxes 245,611 208,209
Other liabilities 96,950 88,673
Total liabilities 4,968,172 4,724,892
Stockholders' equity:    
Preferred stock, $0.0001 par value; 2,000 shares authorized, none issued 0 0
Common stock, $0.0001 par value; 900,000 shares authorized; 600,834 shares issued; 498,972 and 497,809 shares outstanding, respectively 61 61
Additional paid-in-capital 4,428,270 4,184,883
Retained earnings 7,444,115 7,253,431
Accumulated other comprehensive income (loss) (133,047) (169,080)
Treasury stock, at cost (101,862 and 103,025 shares, respectively), net of reissuances (4,490,788) (4,267,715)
Total stockholders’ equity 7,248,611 7,001,580
Total liabilities and stockholders' equity $ 12,216,783 $ 11,726,472
[1] The Condensed Consolidated Balance Sheet as of November 27, 2015 has been derived from the audited Consolidated Financial Statements at that date but does not include all of the information and footnotes required by generally accepted accounting principles for complete financial statements.